ABSTRACT This paper provides a sketch of the emerging role of the pharmaceutical salesman, or 'detail man', in the growth years of the American post-World War II pharmaceutical industry. Using training manuals, trade literature, in-house company newsletters, memoirs, and a variety of other published sources, the paper follows the delicate tactics employed by salesmen and their managers in their attempts to recast drug salesmanship as a 'professional service' fulfilling vital functions within medical education. As they worked to legitimate their presence in the nation's hospitals and clinics, particular emphasis was given to precise management of the etiquette of doctor-salesman interaction. Ultimately, the techniques employed by mid-century salesmen and their managers were to prove successful in generating a widespread acceptance of the industry representative within the clinical spaces of hospital and clinic. Indeed, many of the practices of market research and market strategy employed across the pharmaceutical industry today have their origins in the practices of the individual detail man. Exploration of the postwar pharmaceutical salesman as an overlooked historical 'type' provides significant insights into the intersection of medicine and the consumer marketplace during the later 20th century.
the unique performance, half sales pitch and half educational service, with which pharmaceutical sales representatives present physicians with prescribing information, or 'details', concerning new medications. As historians of general salesmanship have demonstrated, several of the strategies central to the 'everywhere culture' of mass marketing and advertising originally centered on the local culture of the traveling salesman.
3 As such, the local world inhabited by the detail man proves to be a rich intersection of the history of marketing and medicine, a vital link between logics corporate and clinical.
This paper explores the social position and negotiated status of the detail man in the middle decades of the 20th century, a period of intense expansion of the pharmaceutical industry in which many of the structural relations between pharmaceuticals and medical practice were consolidated. Genealogically speaking, the detail man was a not-so-distant relation of the traveling patent-medicine peddler: a commercial traveler, familiar with roadside motels, the inside of his automobile, and with a wary outsider status. 4 But the pharmaceutical representative as a familiar fixture in the physician's office resulted from the dynamic re-organization of the industry immediately after World War II. Though the first salesmen for 'ethical' pharmaceutical houses began their travels across the continent in the mid19th century, the total number of detail men in America was quite small. 5 The 1940s and 50s, however, were a pivotal period for the prescription drug industry, as novel and efficacious medicines began to pump out of a suddenly vibrant research pipeline. Entirely new classes of therapeutic compounds were emerging almost every year, supported by an increasingly systematic body of research and clinical publications. 6 Between 1939 and 1959, sales of pharmaceuticals increased from US$300 million to US$2.3 billion; by 1959 the nationwide corps of detail men had grown from 2000 at the end of the 1920s to more than 15,000 nationwide (Gibson, 1959; Peterson, 1951) .
In this heady climate, detail men re-invented themselves as skilled and service-oriented professionals, the champions of an efficiently modern therapeutics. Their task was portrayed to be apostolic of medical modernity and they set about encouraging the dissemination and consumption of newly synthesized pharmaceutical compounds with a distinctly moral sense of the value of their work. 7 Yet the emissary of a pharmaceutical house did not automatically deserve a seat at the doctor's desk in the discussion of therapeutic options. That space, rather, was always negotiated, with varying degrees of success and frustration. Though their managers formulated marketing strategies from positions of relative power, located within central offices and commanding both sizeable budgets and sales manpower, the individual detail man had no corresponding place to call his own. Since his 'territory' was always a composite of the locales of others -clinics, hospitals, pharmacies -the detail man, like any itinerant performer, had to rely on reflexive tactics to make a place seem like his rightful zone, lest he lose the attention of his audience or, worse, get kicked out of the room. 8 This performance was riddled with anxieties and further complicated by gulfs of age, education, class, and prestige, which intensified the social hierarchy of the doctor-detail man relationship. The self-fashioning of the detail man, then, took place in a charged social space; the legitimacy of his endeavor was everywhere in play through complex relationships of patronage and influence, and the stakes were high for both salesman and company. As individual representatives developed tactics to negotiate this patronage structure and augment the legitimacy and effectiveness of their causes, they sought to control those details left to them in their interpersonal relations: appearance, demeanor, etiquette, and comportment.
9 This paper sets out to examine these tactics as they unfolded in the training manuals, company records, and memoirs of early detail men cautiously carving out a space for themselves between the board room and the consulting room. As they developed a space for themselves within the rhythms and routines of medical practice, these mid-century detail men helped to lay the groundwork for the development of a much more systematic process of pharmaceutical promotion.
'A Highly Respected Profession'
On 30 September 1941, just two months before the America's entry into World War II, Thomas H. Jones addressed an audience of students at Columbia University for the first class ever devoted entirely to the 'detailing' of physicians. Most of the students -including pharmacy students and young employees of local pharmaceutical companies -turned out just to see Jones. He was a veteran salesman, who had received a good deal of attention for a textbook of pharmaceutical selling and he had published the year before (Medical Marketing, 1941d: 3) . The editors of Medical Marketing -a brand-new journal targeted towards an emerging readership of pharmaceutical salesmen and marketing executives -were excited by the announcement of the Columbia course, and saw it as a portent of the new professional status of the pharmaceutical salesman (Medical Marketing, 1941a: 1) . They were concerned, however, that Jones' approach was a bit too anecdotal, 'on the practical, rather than the scientific side' (Medical Marketing, 1941d: 3) .
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In 1941, the drug salesman was largely a specialized variant on the general salesman, his wares differing from those of his competitors chiefly in formulation, 11 and the Columbia course opened with a corresponding definition of the trade as merely another form of selling. Jones told his students:
Webster might define detailing as the telling of a story in all its details . . . but here we will limit the scope of the word, as applied to personal calls upon the doctor, to mean acquainting the doctor with the important facts about a product or products. Detailing is, in reality, sales promotion, and every detail man should keep that fact constantly in mind. (Jones, 1940) By the time the first edition of Arthur F. Peterson's (1949) textbook, Pharmaceutical Selling, 'Detailing', and Sales Training was published nearly 10 years later, pharmaceutical companies were increasingly becoming differentiated by branded product lines grounded in laboratory innovation. 12 Evidence of an increasingly scientific ethos was becoming visible throughout the marketing process, leading to increased calls for rationalization of sales management. Where Jones might teach his sales protégés by anecdote and maxim, Peterson wielded quantitative information and was able to cite from a burgeoning literature of social psychology and marketing research to support his claims. 13 In turn, Peterson's definition of detailing depicted the pharmaceutical representative not as a specialized salesman, but rather as a skilled and respected professional, charged with the vital task of disseminating scientific information to the medical profession:
The well-informed 'detail man' is one of the most influential and highlyrespected individuals in the public health professions. . . . Upon him frequently depends the saving of life or relieving from suffering by virtue of his timely introduction of a therapeutic product and his intelligent discussion of it with a physician. His opportunity to render service of extraordinary value to physicians for the benefit of their patients is in itself a source of real satisfaction. He serves humanity well. (Peterson, 1949: 2) Comparison of these two works, spaced as they are on either side of World War II, begins to document a growing bid for professionalism in pharmaceutical selling as well as the recourse to science, service, and medical necessity that became central to these claims. Until the 1930s many pharmaceutical houses had relied on national wholesalers to distribute their products, and would often contract salesmen through these channels (Galambos, 1991) . By 1940, however, most major houses handled their own distribution, and some of the larger firms -including Parke, Davis & Co., Eli Lilly & Co., E.R. Squibb and Son, Abbot Laboratories, and Burroughs-Wellcome & Co. -had begun to hold in-house training schools before sending their representatives out into the field (Jones, 1940: 31) . In the next 10 years there was a tremendous expansion in the market for prescription pharmaceuticals, as novel classes of therapeutics and individual products expanded at a rapid rate. In the state of New Jersey alone, the number of prescriptions per year had nearly doubled from 7 million in 1936 to more than 12 million in 1946 (Medical Marketing, 1948: 7) .
14 By 1944, there were 7000 detail men in America, and manufacturers were predicting a dramatic increase in the sales force with the end of the war (Medical Marketing, 1944a : 1-8, 1948 . Boosters of the field -Peterson most prominent among them -saw this postwar moment as the selfevident emergence of an efficiently modern profession.
As detail men sought to emphasize their mastery of esoteric knowledge, they often looked towards physicians as models of professional respectability and hoped to attain some measure of respect through emulation. Portions of the American Medical Association's (AMA) Code of Ethics were reprinted in several training manuals, and Peterson's (1949: 334-48 ) Pharmaceutical Selling contained several passages translating the AMA Code into a practicable code of ethics for detail men. The role physicians played as 'model professionals' to detail men can be illustrated by an amusing anecdote from Rufus McQuillan's 1963 memoirs of his early years as the Illinois representative to a prominent drug concern. It appears that one day, after calling on a doctor in downtown Chicago, McQuillan was coming out of his office with his detail bag in hand, which looked very much like a doctor's bag. As he stepped to the curb, 'a woman speaking a foreign language grabbed me by the arm and started to pull me up the street. The more I protested and tried to explain to her that I was not a doctor, the more excited she became and pulled me with all her strength' (McQuillan, 1963: 45) . McQuillan was elated. 'It gave me a much more professional feeling,' he recalled, 'and helped build confidence in myself for my future job ' (1963: 46) .
Though his momentary brush with physician status helped to boost his self-perception as a professional, McQuillan's bid for respectability did not go uncontested. He later describes 'a tough doctor,' who sat quietly during his informational talk and, once the detail was complete, exploded in rage:
'Samples, samples!' he shouted. 'You men come into my office and cover my desk with samples. This is what I think of your samples!'. . . . They all went into the waste basket until it overflowed. The liquid ran onto the floor and the pills bounced in every direction. The doctor was now shouting at the top of his voice. 'Samples! Damn your samples! To hell with them!' (McQuillan, 1963: 56) There is clearly some caricature in this description, and yet such interactions were not isolated experiences in the life of the pharmaceutical representative. A colleague of McQuillan's recounted a related episode from his work in the medical suites of Upper East Side Manhattan. After waiting for a while in the waiting room of an elite practitioner, he was at last met by the physician, who led him through a door and down a long corridor. The detail man thought he was getting a fine reception until they reached the end of the hall, at which point the physician opened the door, and, with a quick push, unceremoniously deposited the company man into the alley. What disturbed the detail man most about this 'insulting doctor' was his inability to understand why '[one] professional person would go so far out of his way to treat another in such an insulting manner' (McQuillan, 1963: 61) .
This embattled claim for professional status on the part of the detail man -specifically in relation to a skeptical medical profession -was reflected throughout the trade literature and guides. As much as they might boast about their public health responsibilities, detail men, and their sales and marketing managers above them, had little immediate power over physicians or ability to bridge the vast distances of social and economic status that separated them. It is perhaps not surprising, then, that the trade literature directed the industry's attention towards ordering those few things they could exercise control over: selection of appealing personnel, management of personal appearance and demeanor, rationalization of labor practices, and explicit categorization of physicians based on the challenges and opportunities each presented for the seller. It is in this arena of etiquette and demeanor that the detail man and the sales managers found some of their most effective strategies for maintaining the appearance of professionalism.
The Raw Goods: Ideal Qualities in a Detail Man
Sales managers attempted to boost the image of their occupation via tight control over the 'quality' of new hires. 'An important factor,' noted one executive in a feature article for Medical Marketing, 'regardless of marketing, is the choice of proper personnel to act as emissaries for the manufacturer' (Folsom, 1948 ). Peterson's textbook (Peterson, 1949: 17-38) devotes an entire chapter to listing the characteristics of the 'ideal representative', including:
Good appearance A pleasing personality A good speaking voice and effective speaking delivery Moderate habits, good health, and physical fitness Alertness, friendliness, and a fighting spirit Integrity, not inclined to make exaggerated claims A good cooperative make-up and the will to work and to follow instructions A good credit report A satisfactory financial status A happy marital status A cooperative wife A good and suitable educational background An inclination to keep abreast of modern pharmaceutical science and service Good retail experience Good organizing ability Compatibility and leadership qualities.
Another guide's inventory of 'positive qualities' included 80 listings, alphabetized like a moral primer: ability, caution, diction, economy, fairness, habits, industry, justice, loyalty, memory, neatness, observation, patience, reliability, sense of humor, tempo, voice, and weight. 15 These are paired against an equally exhaustive list of 'negative qualities', such as affectation, bragging, cheekiness, exaggeration, immorality, 'just get by' attitude, meager or inadequate knowledge, negligence, 'playboy' type, sophistication, trickiness, unreliability, and vulgarity. Many of these virtues reflect the mainstream morality of the increasingly popular 'how-to' business literature popularized by Dale Carnegie in the late 1930s.
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To establish the legitimacy of a pharmaceutical industry presence inside the clinician's offices, it was crucial to select a presentable representative: clean, chaste, moral, married, educated, and pleasant. By 1944, pharmaceutical firms began experimenting with batteries of standardized tests that promised to weed out candidates likely to prove incompatible with physicians (Medical Marketing, 1944b: 2) . A few companies, including Eli Lilly & Co. and Searle & Co., even began to engage the services of fulltime staff psychologists to administer customized psychological testing (Medical Marketing, 1944b: 8) . Many other firms, as part of their regular screening, required interviews with applicant's wives. In part this step was calculated to see if the 'little woman' could tolerate the inevitable separation that long hours on the road entailed, but equally important was the added respectability that a married man brought to the position, relative to a bachelor (Peterson, 1949: 45) .
Sales managers particularly advocated the choice of trained pharmacists as detail men -a tactic chosen to insure that the firm's representative 'talks the same language as the druggist, the hospital pharmacist, and has the ability to efficiently detail a physician' (Folsom, 1948: 3) . Peterson was himself a trained pharmacist, and recruited vigorously from pharmacy schools. His vision of an elite corps of pharmaceutically trained detail men led him on a brief campaign to replace the title 'detail man' with 'Professional Service Pharmacist'. The scientific training of the pharmacist would accentuate the distance between ethical pharmaceutical representatives and old-style patent medicine hucksters. 17 Peterson argued:
There was a time when some pharmaceutical representatives were inclined to 'puff ' the values of their therapeutic products, to make exaggerated claims for them. Frequently it was the result of a representative's lack of scientific knowledge through which he was not conscious of the significance of his claims. (1949: 26) But the detail man of the future would be scientifically trained, a graduate of a college of pharmacy: a Professional Service Pharmacist 'well-versed in chemistry, bacteriology, physiology, and pharmacology [who] obviously thinks as a scientist'. In this sense, Peterson saw it fortunate that pharmacy schools were graduating larger classes, so that 'there are enough salesminded scientists to enable pharmaceutical manufacturers to employ graduate registered pharmacists to carry their messages and discuss them understandingly with physicians from the chemical, pharmacological, and therapeutic points of view' (Peterson, 1949: 26) . The war, and its consequent labor shortage, raised other more pressing questions regarding applicant selection. As dwindling numbers of representatives covered increasingly larger territories, some pharmaceutical houses temporarily did away with their sales forces altogether and relied on direct mail promotions for the duration of the war (Medical Marketing, 1943) . Other manufacturers -including Parke, Davis & Co. -experimented with female and mixed-gender sales forces, though the possibility of hiring African-American or other members of ethnically-defined minorities as sales representatives was never entertained in a trade literature devoted exclusively to the imagery of mainstream white masculinity (Warner-Lambert, 1997: 14).
As was the case in many other wartime industrial settings, the presence of women in the workforce was met with skepticism and heated debate.
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The company man had previously inhabited a characteristically all-male world of travel and business fraternizing, and the 'detail woman' threatened the stability of this universe on multiple levels. 19 Those firms which hired detail women employed a strict and selective model of 'acceptable women': to be considered for employment, applicants were required to be between the ages of 25 and 35 years, with college degrees and some experience in health or nutrition work. Most firms, and most remaining detail men, simply denied the possibility that women could make effective sales representatives, citing certain requirements of the job -such as driving an automobile alone at night, extensive walking, managing a heavy bag full of samples, and coping with uncertain hours -as barriers that categorically ruled out women as candidates. Even those arguing for the inclusion of women in the ranks tended to agree that their utility was necessarily limited. 'Much depends on the nature of the product,' demurred one sales manager, 'and I doubt the value of women in detailing on any but the simplest pharmaceuticals' (Medical Marketing, 1942: 1-3) . After the war, however, the point quickly became moot: by 1950, women were all but excluded from the sales force once again; for most firms the phrase 'detail man' described the gender realities of pharmaceutical selling until the mid-1970s.
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Trainable Habits: Grooming, Comportment, and Demeanor
In a very tangible sense, the detail man was seen as the company itself on public display (see Figure 1) . ' [T]ake a full length look at yourself each morning,' one guide to detailing observed, 'and be sure you furnish a proper background for the product to which your firm has generated so much time and thought' (Jones, 1940: 104) . As the detail man was an extension of the product packaging, it was essential that his appearance be well maintained, 'so the doctor's first reaction will be, "Well, they thought enough of this product to put it in a good-looking package"' (Jones, 1940: 104) . Conscious efforts were made to mold the detail man's appearance into something that marketing managers saw as emblematic of their strategic goals.
The representative's fashion-sense was constrained, however, by the nature of his selling context: it was imperative for his image to be respectable, and suitable for a doctor's office. Just as a slovenly dressed or unhygienic salesman set an automatic hurdle of sales resistance, a toosmartly dressed, excessively cosmopolitan individual might provoke skepticism in the prospective physician. 'A man who dresses conservatively,' one guide concluded, 'and thus does not distract the prospect's attention from the sales story presents the best appearance from the operative-sales point of view' (Peterson, 1949: 17) . Personal appearance became particularly problematic for the few women involved in detailing. Although attractive personal appearance generally was seen as a boon for detail women, 'too much beauty' was considered a distinct disadvantage. 'We don't accept the model type,' noted one company representative. 'Our detail women have a serious professional job to do. We want the physician's mind on our product, not on the personal attraction of our representative' (Medical Marketing, 1942: 1) .
With the corpus of their work force well-groomed, sales managers extended their sights to the physical and moral hygiene of their charges. Letters, editorials, and guides emphasized that good diet, exercise, moderation in drink, politeness, overall sense of manners, posture, and propriety could be as important as pharmacological knowledge in producing a successful detail man. Sales trainers and managers, furthermore, were not the only watchdogs of their employees' comportment. One detail man recalls a physician who interrupted him in the middle of his 'detail', pulled him aside, and mentioned:
You know, when you used the word 'deteriorate' you pronounced it wrongly. You left out a syllable, as State-of-Mainers are apt to do; you pronounced it de-te-o-rate. Now you know you represent a good firm and you are a nice young fellow. On your kind of job you should be very careful that you always pronounce your words correctly. If not, it reflects both on you and your firm. I hope you will not be offended by my correction, but I am doing it for your own good. (Jones, 1940 : 52-3) Detailing required a creative, improvisatory 'personality', but the company's man was tightly constrained in his presentation of self. To present himself as the earnest emissary of his company was difficult enough. To present himself as a worthy interlocutor of his physician-client was another task altogether.
Overcoming 'Doctor Fright': Scripting the Pitch
The detail man's claims to legitimacy hinged upon the promise of educating physicians about novel and efficacious therapeutics. And yet this placed the representative in the tenuous position of a layperson educating doctors on how they should be practicing medicine. At a time when the collective of medical practitioners was almost entirely self-regulated and self-reliant, many detail men had difficulty inserting themselves into the clinical world.
21 Several expressed great trepidation at approaching physicians, particularly academic physicians. This phenomenon, labeled 'doctor fright' by managers and sales trainers, was seen as a hazing ritual through which all detail men needed to pass. As they developed strategies to overcome their fear of medical authority, individual detail men negotiated the penetration of a marketing instrument deeper into the workings of US medical practice.
An entire chapter in Jones' text Detailing the Physician is given to the subject of 'Overcoming "Doctor Fright"'. With work and determination, Jones insisted, the freshman sales representative could get past his initial sense of physicians as untouchable elite, and recognize that 'human beings all over this land of ours are very much the same' (Jones, 1940: 52) . Explicitly referencing Dale Carnegie, Jones suggested that the trick to overcoming one's fears of illegitimacy lay in projecting a strong positive mental attitude and a thorough knowledge of the subject material. Detail men particularly needed to work to overcome the 'plate glass shyness', that could come at the doorways of famous or 'V.I.P.' practitioners (Peterson, 1949) . Jones illustrated with the hypothetical 'Dr. Toughnut, Professor of Clinical Medicine, at the University', who, upon closer inspection, turned out not to be a 'surly looking, domineering old grouch at all'. Rather, as the confident salesman will find, 'when you have brought your talk to the final point, you will discover that Dr. Toughnut is really Dr. Goodfellow' (Jones, 1940: 59-60) .
The trick was to internally visualize the physician as a benign everyman, while externally treating him as a sort of scholar-prince. 22 In-house training programs used photographs, films, and text to explicitly spell out the subtler body-language and etiquette by which detail men could identify their relationship with physicians as both respectful and professional, beginning with the handshake. 23 The physician must always be allowed to offer his hand first: Naturally, the physician will not shake hands if he has not removed his rubber gloves. When the P.S.P. [pharmaceutical representative] prepares to shake hands with the physician, he should 'measure off ' the proper distance between them. He should stop in such a manner that the body is naturally erect and relaxed, the right foot about a short step in advance of the left. He can then bow very slightly from the waist as a full grasp is taken of the physician's hand. (Peterson, 1949: 271-72) Only after the physician was seated was it appropriate for the company man to seat himself. Detail men were trained to adopt an 'across the corner' position if possible (see Figure 2) . To sit directly across the desk from the physician would be to assume the role of patient; to sit on the same side would be to arrogate, prematurely, the status of colleague. Sitting across the corner gave the detail man space to claim the identity of an allied field -literally, a right-hand man (Jones, 1940: 45; Peterson, 1949: 272-73) . The remainder of the detail man's body movements were also carefully scripted: the placement of his hat (on the floor, never on the desk), the location of his 'detail' bag (on the lap, for fluidity of sample retrieval), and the propriety of smoking in the office (never, not even if the physician offered: a detail man required both hands and mouth free at all times).
24 All motions must be deferential, efficient, calculated to nurture the physician's sense of self-importance and the detail man's sense of professionalism.
Once the blocking for the scene had been scripted, the content of the educational pitch was modulated just as closely. The extent to which a salesman could explicitly attempt to alter a physician's therapeutic practice was always a delicately negotiated thing. The experienced man knew that 'nothing antagonizes a doctor quite as much as having a detail man attempt to teach him his profession' (Jones, 1940:44) . And yet, as several authors pointed out, the fundamental purpose of detailing was ultimately a bid to alter the individual clinician's therapeutic thinking, at least in those areas related to the company's products. Herein lay the detail man's dilemma: how could an outsider develop a voice within a traditionally exclusive and elite profession?
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One strategy for circumventing this dilemma, known as 'Assume Physician Knows', entailed a rhetorical couching of one's sales pitch as if it were merely a piece of knowledge that the doctor already possessed. Like a cuckoo hen slyly inserting her own egg into another's nest, the detail man could camouflage company material within parcels that physicians might mistake as part of their own knowledge. Formulas such as 'I presume you are familiar with X' and 'You are aware, I know, that X, but I should like to take a moment to emphasize Z' were presented in tables for detail men to memorize. These lists were flanked by columns of 'poison' phrases -to be avoided at all costs -such as the unctuous 'I should like to enlighten you . . .' and the fatal 'You are not treating the patient correctly.' 26 Another method of suggestion was to quote other doctors -either from their published work or from independent conversations -so that authority over therapeutic decision-making might merely be transmitted from one doctor to another. Quotation allowed the detail man to suggest therapies through a pastiche of other practitioners' terms, while never exposing his own tenuous position.
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'There is a marked difference,' one training text claimed, 'between making a suggestion and making a positive statement.' Detail men were cautioned against being 'offensively aggressive', but encouraged to make use of areas of the acknowledged uncertainty of clinical practice. No physician, one text claimed, was '100% sure about the behavior of a drug . . . [o] n the other hand, he will welcome a suggestion relative to the clinical application of the product' (Jones, 1940: 68) . Physician surveys indicated that doctors preferred this lighter touch, and highlighted the 'ideal detail man' as one who 'gives the physician maximum information, minimum argumentation', and thereby 'serves rather than sells'. 28 To phrase an argument regarding propriety and impropriety in therapeutics was to overstep his role. But the detail man who re-packaged his arguments in terms of informational 'facts' -preferably facts that seemed like public knowledge -was perceived by physicians as providing an educational service.
These strategies to delicately accentuate the 'educational' aspects of detailing over the 'selling' side played out with variable success in the real face-time of detail calls over the course of the postwar era: 18,750,000 calls per year, or seven calls per doctor per day by 1959 (Gibson, 1959: 463) . Some physicians summarily refused to see detail men, others wrote extensively on the educational value of pharmaceutical representatives; one physician suggesting that 'in many ways [the detail man] can impart the means whereby the doctor can receive a postgraduate course in medicine.' 29 Though surveys of physicians suggest that detail men were on the whole well-received in doctors' offices during this period, sales representatives could still count on receiving a good deal of frustration and indignation at the hands of their 'prospects' (Medical Marketing, 1941b: 8) . This too, they sought to manage, tackling the 'problem physician' as a research subject and subdividing it into types: creating, in the process, a sort of botanical field guide to prickly or poisonous practitioners.
A Field Guide to Bad 'Prospects'
'Just as the rose picker finds an occasional thorn,' one guide pointed out, 'so you will find thorns among the doctors' (McQuillan, 1963: 131) . Knowing where to expect resistance -and which tactics worked best with particular forms of resistance -became an organizing principle for detail men attempting to resolve their ambivalent status. To assist themselves in this process, detail men compiled informal bestiaries filled with caricatures of resistant or difficult physicians. In addition to their training value, these taxonomies acted to create a language by which the pharmaceutical industry could began to study the market behaviors of those intermediaries it was trying to influence.
If these characters, with names like 'Dr. Resistant' and 'Dr. Snob' were a bit overdrawn, they were also commonsensical, reflective of broadly shared experiences of frustration and exclusion. Well-displayed in the bestiary was the unfriendly and skeptical doctor, who categorically disliked all detail men because he thought that they exaggerated or overestimated their products. According to one guide, it was no use even trying to talk with a physician so set in his doubts (McQuillan, 1963: 131) . Others disagreed, suggesting that no doctor was a lost cause, and that perseverance and mettle would suffice to win over even the most skeptical of physicians.
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The back-slapper, however, was a trickier species to identify and handle: facile and entertaining, he made it difficult for a detail man to know whether he was meeting with any success. 31 He would laugh at all of one's jokes, claim to use one's products and yet remain inscrutable and aloof. Equally difficult to get a bead on was the silent one, who could listen to a full presentation without mentioning a word. With thought and planning, he could be drawn out, bit by bit, into open conversation. Special caution was urged when handling the decided, self-confident type: a particularly difficult and stubborn-headed physician, who didn't like to take advice from non-physicians (McQuillan, 1963: 132) .
These 'types' were flexible and expandable as the individual salesman saw fit. 'A good salesman,' as one detail man claimed in his memoirs, 'must be a good practical psychologist -studying his prospects all of the time and thus being ready to go along in step with them' (McQuillan, 1963: 132) . But this individual 'psychologizing' was soon placed in relation to more strategic goals of market research. Peterson, in his 1949 guide to detailing, proposed a standardized method of rating physicians that differed significantly in its embrace of multi-axial and quantifiable market research. Physicians were to be gauged on two axes, the first -graded 'A' to 'E' -assessed their potential patient volume, the second -graded 'V' to 'Z' -rested on their attitude towards medical innovation.
'A' physicians had large practices, prescribed a good deal, and were well-connected with hospitals and academia; 'B' physicians had fewer connections; 'C' physicians were young and had growing practices; 'D' physicians had stable practices that were not likely to grow; while 'E' physicians were simply described as 'not worth calling upon.' On the second axis, the 'V' physician was 'honest in his use of [samples] for clinical research only. He will most likely write for publication.' 'W' physicians were honest but not likely to publish, while 'X' were not investigators, and should only receive samples during special launches. 'Y' physicians, on the other hand, were 'sample grabbers': '[o]ne who requests samples for the real purpose of treating his patients instead of buying the product through ethical outlets' (Peterson, 1949: 84) . Based on these two coordinates, the detail man could plot out the more and less favorable regions of his territory, and prioritize his promotional efforts accordingly.
Peterson's system was designed to visualize marketing challenges through figures, tables, graphs, and charts. As such, it represented a transitional step between the anecdotal use of 'problem physicians' -as common referents for identification and training -and the growth of an infrastructure of market research that provided an increasingly clearer perspective on prescribing practice and how it could be influenced. This sort of data-oriented recursive practice would, by the late 1950s, become standard in most pharmaceutical marketing departments, and in the 1960s would lead to the establishment of vast pharmaceutical marketing databases, such as the IMS Health data empire. 32 The origin of these marketresearch practices, however, lay in the quotidian successes and frustrations of the individual detail man.
Conclusion: Tides in Selling that Influenced Disease
The journal Medical Marketing ran a regular feature throughout the 1940s entitled 'Tides in Disease that Influence Selling' (Figure 3 ), which focused on broad questions of epidemiology as they referred to the particular needs of the pharmaceutical salesman. Which states had the highest rates of degenerative conditions? What time of year were people having the most cold symptoms? The issues could be demonstrated with the aid of 'marketing maps' that plotted space and time to demonstrate the striking imagery with which new quantitative market research could generate information of strategic use to the detail man and his sales managers.
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By the late 1950s, however, a reciprocal flow in market research was becoming noticeable. Marketers began developing strategies based on information collected by the detail man. Representatives were sent out into the field to monitor their interactions with physicians, to determine in a quantitative fashion which selling practices worked and which didn't. As detail-based marketing tactics became more and more sophisticated, new 'marketing maps' appeared that included, in addition to epidemiologic data, an increasingly sensitive image of which doctors were prescribing which drugs, to whom, and in response to which promotional campaign. Sociologists of innovation and market researchers alike began to use the detail man as an instrument of data collection, building from Peterson's two-axis system of doctor-rating to highly sophisticated real-time models of physician prescribing behavior. The clarity with which the pharmaceutical industry could peer into the practice of medicine was becoming sharper than anyone had ever predicted.
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The mid-century emergence of the professional detail man marked an important point in the co-evolution of the medical and pharmaceutical practices. The detail man does not represent any novel 'intrusion' of the marketplace into the practice of medicine, 35 but I will maintain that he represents another, more subtle 'first': the extension of a hierarchically structured marketing apparatus -based on rationalized principles of management and market analysis -into social spaces previously thought to be occupied only by doctors and patients. As detail men tiptoed their way around 'educating' physicians about their products, they cautiously laid the groundwork for a largely accepted role of the industry in the formation and dissemination of therapeutic knowledge. 
Greene: Attention to 'Details'
Over the latter half of the 20th century, the pharmaceutical industry has stepped more confidently into those positions so carefully negotiated by early detail men. Pharmaceutical representatives are still relied upon for their educational function, and a high percentage of physicians continue to list these 'reps' as the most important source for information on new drugs (see Lexchin, 1993) . The second most commonly used source of new drug information -the Physicians' Desk Reference -is also a voluntary private service that began to be provided by the pharmaceutical industry in the immediate postwar period (Medical Economics, 1946) . Continuing Medical Education (CME) courses, the means by which physicians are expected to regularly keep up with medical innovations, are now overwhelmingly funded and produced by pharmaceutical companies or their independent subsidiaries. Pharmaceutical representatives are a welcome fixture at most medical schools and residency programs; their companiesand the meals and gifts they provide -are often relied upon as a fundamental institutional context of medical education.
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Earl Shorris has suggested that the cultural imagery of the US salesman has been split between two Edenic parables. The first views the salesman as culture bearer, a vital and vibrant usher of modernity and progress. The second casts the salesman as corrupting influence, a vector introducing the seeds of base commercialism into a previously pristine landscape (Shorris, 1994) . The detail man never became a 'public health professional'; in spite of his claims of a 'vital educational function' he would, in the eyes of the medical profession, continue to be known chiefly as a salesman. Nevertheless, the detail man found success as a fundamental link in the system of pharmaceutical-physician relations, a bridging figure who functioned effectively to promote novel medications and to speed their uptake and diffusion throughout the prescribing medical public. That the detail man could simultaneously fail in his bid for professional legitimacy, and yet still find himself generally welcome throughout the medical system, is on the whole emblematic of the conflicted and highly ambivalent relationship between medicine and the consumer market place in late 20th-century America. NJ, USA) added significantly to the research project. Finally, the author would like to thank the two anonymous reviewers for their helpful suggestions in bringing this paper towards publication. 2. According to data from a Reuters Business Insight report to the pharmaceutical industry, the 50 top-grossing pharmaceutical companies in 2001 spent US$25.5 billion, or 75% of their total prescription-drug marketing budget, on detailing efforts in that year. This represents more than nine times the US$2.8 billion these companies outlaid the same year on direct-to-consumer advertising (Reuters, 2002: 19-25) . 3. The historiography of salesmanship is limited, but includes a set of well-integrated late19th and early 20th-century case studies by Friedman (1996 Friedman ( , 2002 , the American studies approach of Spears (1995) as well as the social-historiographic characterization of Zunz (1990, see in particular, Ch. 7 : 'Drummers and Salesmen') and Strasser (1989) . Young's (1961) analysis of the performances of 19th-century patent medicine salesmen is a crucial link between the historiography of general salesmanship and the pharmaceutical salesman. 4. Spears (1995) describes at length the liminal character of the late 19th-century traveling salesman in relation to other itinerant figures such as the vagrant and the hobo. The kinship of the pharmaceutical salesman with the patent-medicine huckster, however, had a more immediate effect on detail men's self-representation (see Young, 1961) . 5. The term 'ethical pharmaceuticals' -still in use today to denote prescription pharmaceutical products and their manufacturers -took its meaning from the effort of late-19th century pharmaceutical houses to differentiate themselves from patentmedicine salesmen by voluntarily imposing an injunction against advertising directly to the lay public, after the AMA Code of Ethics (Liebenau, 1987) . 6. In the first half of the 20th century, the Council on Drugs of the AMA assumed a prominent role in the evaluation of novel therapeutics and promotion of their proper usage by the practicing body of physicians. However, by the late 1940s, the increased number of novel therapeutic compounds overwhelmed the capacity of this office of the AMA, and by 1955 the Council on Pharmacy and Chemistry had largely ceded responsibility for therapeutic evaluation and promotion to the Food and Drug Administration (FDA) and the pharmaceutical industry, respectively. Dowling (1970: 171-77) notes that the cessation of their Seal of Acceptance program was likely brought about largely by the financial pressures of advertising revenue and a costly antitrust prosecution against the AMA. The AMA's responsibilities for therapeutic evaluation had by that time been made largely redundant through the expansion of the FDA under the powers of the Food & Drug Act of 1938; the cessation of its educational responsibilities, however, left a more significant vacuum. For a more detailed description of this process, in the context of the emergence of the large-scale clinical trial, see Marks (1997b) . 7. The term 'apostles of modernity' was coined by Marchand (1985) to describe the modernist self-conceptualization of advertising agents in the seminal period of advertising development between 1920 and 1940. 8. I am here following the distinction between strategies and tactics as set forth by Michel de Certeau (1984 de Certeau ( [1980 ). According to de Certeau's definition, precisely planned 'strategies' are only available to those operating from loci of power; 'tactics' are more or less a set of street sensibilities. 9. Several relevant studies of the etiquette and patronage economies as related to the exchange of ideas have been produced in recent years, many of which touch back to Elias' (1982 Elias' ( ], 1983 ) cultural analysis of the rise of courtly society and manners as well as an anthropological literature on the social obligations entailed in gift exchange rooted in the works of Mauss (1990 Mauss ( [1925 ) and Malinowski (1920) and the recent popularity of anthropological theories of practice (for example: de Certeau, 1984 de Certeau, [1980 ; Bourdieu, 1990 Bourdieu, [1980 ). For studies explicitly using frameworks of etiquette to understand the presentation and dissemination of scientific knowledge, see Shapin (1988) and Biagioli (1992 Medical Marketing (1941d) . In the 20-year span from its launch in 1941 to its consolidation into a more general publication in 1960, the pages of Medical Marketing strove to emphasize a new 'scientific' approach to the marketing of medicines. 11. This is well described in much of Dowling's work (1970) as head of the AMA's Council on Drugs for most of the period described. See also Silverman & Lee (1974) . 12. Merck, for example, released Cortone (cortisone) in 1949, its first drug marketed as a brand-name product rather than a chemical formulation (Marks, 1992) . 13. Peterson's book was well known within the industry. By 1968, it had been through three editions with wide readership and international publication (Kremers Reference Files, 1968). 14. These figures must be read with some caution, as the regulations surrounding prescriptions changed significantly with the passage of the 1938 Food and Drug Act, which added federal enforcement to exclude the sale of non-over-the-counter drugs without prescriptions (see Temin, 1979; Marks, 1997a) . The increase in prescriptions is nonetheless quite significant for the growth of prescriber-oriented marketing tactics. 15. The full list is too long to reproduce here (see Peterson, 1949: 42 Salesmanship, Science, and Magic, 1880 to 1940. 17 . This mobilization of an imagery of professionalism in order to sever links between the modern salesman and the blustery huckster of a past era is not unique to the realm of pharmaceutical salesmanship. In Spears ' (1995) analysis, a lingering cultural mistrust of the traveling salesman can be traced partly to his kinship with 19th-and 20th-century US itinerants, such as the vagrant, the hobo, and the con artist, which causes the traveling salesman to teeter continually between respectability and crassness. 18. For a concise discussion of the conflict and frustrations surrounding women and minority inclusion in the wartime industrial economy, see Hirsch (1996) . 19. Witness, for example, the alarmist subtitle to the following source: 'Detail Women: Can Women Replace Men in Detailing Physicians? ' (Medical Marketing, 1942: 1-3) . 20. For example, of sales hiring practices over the century at Merck, see Galambos (1991) . 21. Most standard accounts posit the mid-20th century as the apogee of autonomy and prestige for the medical profession (see Starr, 1982; LeFanu, 1999) . 22. The term 'scholar-prince' is used loosely here to refer to the relative professional autonomy of the medical profession at this time and to cast the physician's position in a suggestive context of courtly etiquette and patronage structure. For an example of related scholarship on patronage structure of medical practice in early modern Europe, see Moran (1990 Folsom (1948: 3) . 24. These examples all come from Peterson (1949: 273-75) . 25. In trying to understand the charged patronage structures in which early detail men went about their promotional tasks, it is useful to make an overly simplified analogy to a much different historical period. The role of the detail man was in many respects not dissimilar to that of the councilor or the advisor to the king within early modern courtly society. In an era of absolute rulers, knowledge itself was often seen to reside absolutely in the person of the potentate, rendering the task of advising the ruler a thorny one indeed. In order for an advisor to advise one whose wisdom was supposed to encompass all subjects far more serenely than that of the advisor, councilors relied on a set of rhetorical devices to couch their suggestions as items that had already resided in the most perfect intelligence of their ruler (Hocart, 1970 (Hocart, [1936 ) ; Ferster, 1996) . At the same time as the king received the complimentary flourishes of his advisor's entreaties, however, a tacit understanding existed between the two that the king did, in fact, require the advice of his councilor. The overt appeal to the wisdom of the king, like the explicit appeal to the knowledge of the physician, could be seen as a ritual of status maintenance, a performative process upon which both of their identities were dependent. The dependence of the detail man's occupational identity on the physician has already been made clear in the earlier sections; the degree to which physicians' status became dependent upon visits by detail men is harder to establish, though hints of such a process are visible in the writings of physicians of the 1940s and 1950s regarding the indispensable 'educational' value of visits from pharmaceutical representatives. A further analysis regarding the status-functions of the gift economy between detail men and physicians will be developed in a future publication. 26. The examples mentioned come from Peterson (1949: 275-76) . Other recommended phrases included: 'I presume that you have heard X', 'You will recall that Y', and 'Just as a reminder, Z'; further examples of 'never-use' phrases included 'Do you understand X?', 'Don't do it that way', and, emphatically, 'Do as I say and you can't go wrong.' 27. Quotation, however was not universally safe: 'There is always a danger, in this quoting business, that you may refer to a man for whom the doctor you are detailing has little or no respect' (Jones, 1940: 70) . 28. Physicians, it appears, concurred with the sales managers: in a 1941 survey conducted by Medical Marketing, practicing doctors cited 'extravagant claims that insult the physicians' intelligence' and 'reading lengthy clinical reports going unduly into detail about the chemistry of the product' as two of the 'worst qualities' found in detail men (Medical Marketing, 1941b: 8) . 29. Quote attributed to anonymous physician, as cited in McQuillan (1963: 137) . 30. Another 'problem physicians' was the price buyer, a species who thought that many of the better houses charged too much for their drugs and believed all drugs to be alike and therefore consistently preferred the cheapest medicines available -regardless of the well-positioned data and arguments of the detail man. He had developed, in the terms of the trade literature, a 'price complex': unable to be swayed by the improvements of modern pharmacy. The remedy that the guides offered to detail men struggling with price buyers was sheer persistence: at times they could be won over by sound reasoning and good handling, with particular emphasis given to the importance of therapeutic innovation (see Peterson, 1949) . 31. McQuillan (1963: 132) writes of the 'back-slapper' physician: 'He is your best prescriber in the country according to his estimate. He will slap you on the back, shake your hand, and take over all of the conversation. You find it almost impossible to get in a word about your products. He loves all salesmen, and is a friend to all mankind -or so he says. THIS MAN IS HARD TO SELL.' 32. IMS currently manages a series of databases including the National Prescription Audit and the National Disease and Therapeutic Index. The former uses pharmacy records to provide highly sophisticated geographic breakdowns of prescription rates and sales volume down to the zip code, while the latter maintains a panel of physicians to map drug sales and prescription rates to diagnostic categories (see Lakoff, 2004 Katz & Menzel (1955) , sociologists from the Columbia-based Bureau of Applied Social Research; the Bureau conducted studies for pharmaceutical clients that used the detail man as a 'probe' to measure the spread of prescribing habits through physician populations. See also their book-length work, published under the title Medical Innovation (Coleman et al., 1966) . It should be noted that the use of the salesman as a tool for market research was in no way unique to the pharmaceutical industry; indeed, the role of salesman as unit of information technology is well described in late 19th-century case studies of American Tobacco, McCormick, and DuPont by Chandler (1977: 219, 309, 385, 411, 442) . By reporting on changing demand, desired items, and economic conditions of different geographic regions and market sectors, salesmen in these fields were vital instruments of the new science of market research. Equally significant was the role of the salesman as an extension of new principles of managed distribution: Chandler traces the motion of salesman through their efficiently organized 'territories': moving 'by the cars' of the railroad and then by horse and buggy from his manager's office to 'the smallest and most distant of country stores' across the country. Though the salesman is just one of many figures in his book -and a minor one, compared with the middle manager -Chandler works to detail the rise of efficiently managed, centrally controlled, professionally trained sales forces of nationally distributed brands that antedate the marketing practices of the pharmaceutical industry. 35. There is a growing literature documenting the importance of marketing in the practice of medicine long before the period discussed in this paper. Tomes (2001) provides an overview of this nexus, as well as an engaging case-study of the role of consumerism in the promotion of germ theory (Tomes, 1998) . 36. There is an emerging social science literature on the social networks and relationships through which pharmaceutical representatives currently influence medical practice: for example, Peay & Peay (1988) , Lexchin (1993), and Wazana (2000) .
